SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-102073
Filing Date
2023-04-14
Accepted
2023-04-14 16:12:38
Documents
6
Effectiveness Date
2023-04-14

Document Format Files

Seq Description Document Type Size
1 S-8 d422934ds8.htm S-8 51492
2 EX-5.1 d422934dex51.htm EX-5.1 6223
3 EX-23.1 d422934dex231.htm EX-23.1 1413
4 EX-FILING FEES d422934dexfilingfees.htm EX-FILING FEES 13662
5 GRAPHIC g422934g0413235616317.jpg GRAPHIC 4100
6 GRAPHIC g422934g0413235616482.jpg GRAPHIC 7076
  Complete submission text file 0001193125-23-102073.txt   89487
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-271264 | Film No.: 23821290
SIC: 2834 Pharmaceutical Preparations